Gene · 2222
Papers2,006
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,006
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retraction Note: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression. | Nat Commun | 2025 | 41115872 | PubTator, text mining | PubMed |
| Unraveling the Potential Pathogenic Role of Squalene Synthase (SQS) in Lung Cancer Using Enzyme Inhibitors as Molecular Tools. | ACS Med Chem Lett | 2025 | 41089479 | PubTator, text mining | PubMed |
| Study of mechanism of drug-induced liver injury caused by pyrethroid insecticides based on network toxicology and mendelian randomization. | Toxicol Res (Camb) | 2025 | 41078562 | PubTator, text mining | PubMed |
| Genomic relationship between polycystic ovary syndrome and bipolar disorder. | Res Sq | 2025 | 41041534 | PubTator, text mining | PubMed |
| Salinity Modulates Carbon Flux to Promote Squalene and PUFA Biosynthesis in the Marine Protist Thraustochytrium. | Mar Drugs | 2025 | 41003323 | PubTator, text mining | PubMed |
| Untargeted GC-MS Metabolic Profiling of Anaerobic Gut Fungi Reveals Putative Terpenoids and Strain-Specific Metabolites. | Metabolites | 2025 | 41002962 | PubTator, text mining | PubMed |
| Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer. | Cell Death Discov | 2025 | 40998801 | PubTator, text mining | PubMed |
| Publisher Correction: NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation. | Oncogene | 2025 | 40983637 | PubTator, text mining | PubMed |
| Multi-modal characterization of metabolic and immune gene clusters in adrenocortical carcinoma treatment. | NPJ Precis Oncol | 2025 | 40968257 | PubTator, text mining | PubMed |
| Impact of HIV-1 Tat on FDFT1 Suppression, Changes in Cholesterol Level, and KSHV Replication in BCBL1 Cells. | Curr HIV Res | 2025 | 40947702 | PubTator, text mining | PubMed |
| EMC2 promotes triple negative breast cancer growth by protecting FDFT1 from endoplasmic reticulum associated degradation to impair ferroptosis susceptibility. | Oncogene | 2025 | 40931051 | PubTator, text mining | PubMed |
| NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation. | Oncogene | 2025 | 40890513 | PubTator, text mining | PubMed |
| Suppression of SREBP by a transmembrane protein mutated in cardiomyopathy. | J Biol Chem | 2025 | 40885397 | PubTator, text mining | PubMed |
| The instrumental role of lipids in governing the sensitivity of multiple myeloma to ferroptosis. | Discov Oncol | 2025 | 40853521 | PubTator, text mining | PubMed |
| The expression of transmembrane channel-like 5 in gastric cancer and its impact on tumor progression. | Sci Rep | 2025 | 40851023 | PubTator, text mining | PubMed |
| Iron metabolism and ferroptosis in human health and disease. | BMC Biol | 2025 | 40846971 | PubTator, text mining | PubMed |
| Epigenomic Interactions Between Chronic Pain and Recurrent Pressure Injuries After Spinal Cord Injury. | Epigenomes | 2025 | 40843668 | PubTator, text mining | PubMed |
| Ginsenoside 20(S)-Rg3 upregulates SQLE to reprogram cholesterol metabolism of ovarian cancer cells. | iScience | 2025 | 40792023 | PubTator, text mining | PubMed |
| Effect of TP53 mutation, expression and polymorphism on the survival, immune infiltration and ferroptosis in patients with prostate cancer. | Oncol Lett | 2025 | 40740989 | PubTator, text mining | PubMed |
| Pulsed electromagnetic stimulation promotes neuronal maturation by up-regulating cholesterol biosynthesis. | Stem Cell Res Ther | 2025 | 40713855 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2222/papers?page=4